Boston Scientific
Bookmark
ShareBoston Scientific is a company. It is located in Marlborough, the United States and was founded in 1979. The company is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Marlborough
- state: MA
- country: United States
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 1979
- CEO: Michael F. Mahoney
- CEO gender: Male
Classified as: organization
Business
Boston Scientific is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care and 3,550,070 companies in our database.
- Assets: 32.2B $
- Debt: 9.7B $
- Employees: 41,000 people
- Market cap: 58.2B $
- Profits: 1B $
- Revenues: 12.3B $
Stocks from Boston Scientific:
Talking Points
- Advancing Science for LifeUS
- Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
- Official news from Boston Scientific, a leading innovator of less invasive medical solutions that transform lives around the world. (NYSE: $BSX)
- Advancing Science for Life | At Boston Scientific, we work collaboratively to solve healthcare's toughest problems by developing solutions that matter most to those suffering from debilitating and life threatening conditions and the healthcare professionals who provide their care. Across 100+ countries, we help providers deliver care more ...
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Learn more about talking points
